Re-Connect App for Smoking Cessation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a smartphone app called Re-Connect, which helps people quit smoking by restricting access to non-essential apps unless they meet specific smoking abstinence goals. The study examines the practicality and effectiveness of this approach in aiding smoking cessation. Participants are divided into two groups: one can unblock apps by submitting breath samples, while the other must meet specific smoke-free goals to unblock apps. This trial suits individuals who smoke at least 10 cigarettes a day, want to quit, and frequently use a smartphone. As an unphased trial, it offers a unique opportunity to explore innovative methods for smoking cessation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on smoking cessation and smartphone app use, so it's best to ask the trial organizers for more details.
What prior data suggests that the Re-Connect App is safe for smoking cessation?
Research has shown that smoking cessation apps, such as the Re-Connect app, are generally safe for users. For instance, a study of the Ex-Smokers iCoach app, used by over 400,000 people in Europe, found no major safety issues. These apps typically offer personalized plans to help users quit smoking and manage cravings. Since the Re-Connect app functions similarly, it is likely safe for most users.
It is also important to note that this trial tests a digital tool, not a new drug or medical device. This generally means a lower risk of side effects compared to trials involving new medications. Overall, using an app to quit smoking is considered a safe option for most people.12345Why are researchers excited about this trial?
Researchers are excited about the Re-Connect App for smoking cessation because it offers a fresh approach by using digital incentives to encourage quitting. Unlike traditional methods like nicotine replacement therapies or prescription medications, this app leverages behavioral strategies through its unique contingency models. The Abstinent Contingent (AC) arm of the app allows users to unlock desired apps like social media or games only if they meet specific carbon monoxide goals, providing an immediate, tangible reward for staying smoke-free. Meanwhile, the Submission Contingent (SC) arm offers flexibility by allowing users to unblock apps by simply submitting carbon monoxide samples. This innovative use of technology and behavior reinforcement could make quitting smoking more engaging and personalized, increasing the chances of success.
What evidence suggests that the Re-Connect App is effective for smoking cessation?
Research has shown that smartphone apps can help people quit smoking. One study found that digital tools for quitting smoking have high success rates, with one app reporting that 56% of users quit smoking over a year. In this trial, researchers are testing the Re-Connect app in two different approaches. The Abstinent Contingent (AC) Re-Connect arm blocks access to non-essential apps unless users meet their smoking abstinence goals, verified by carbon monoxide levels. The Submission Contingent (SC) Re-Connect arm allows users to unblock their applications contingent on submitting carbon monoxide samples, independent of meeting abstinence goals. Evidence suggests that using apps like Re-Connect can effectively support efforts to quit smoking.16789
Who Is on the Research Team?
Bethany Raiff, PhD
Principal Investigator
Rowan University
Are You a Good Fit for This Trial?
This trial is for adults who have smoked at least 10 cigarettes daily for over 2 years, want to quit smoking (strong desire), can use a smartphone, and speak English. They must not have health issues like severe lung conditions or unmanaged mental health problems.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Usability and Acceptability Testing
Small focus groups and feedback sessions to gain insight into the acceptability and usability of Re-Connect, followed by single-case design studies for extended app use
Randomized Control Trial (RCT)
Pilot RCT to test feasibility, acceptability, and preliminary efficacy of Re-Connect with two groups: Submission Contingent and Abstinent Contingent
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Re-Connect
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rowan University
Lead Sponsor
University of Kentucky
Collaborator